Table 2.
Open in new tab

Therapeutic outcomes* at initial restaging.

PERT
(n = 188)		No PERT
(n = 313)		P-value
Received intended cycles of therapy, n (%)155 (82.4)236 (76.0).08
CTC grades 3 and 4 toxicity, n (%)14 (7.5)29 (9.3).60
Toxicity-related hospitalization, n (%)11 (5.9)13 (4.2).28
Percent change in CA 19-9, mean (SD)-54.4 (56.9)7.0 (453.1).14
Radiographic response partial/stable, n (%)161 (85.6)245 (78.3).09
PERT
(n = 188)		No PERT
(n = 313)		P-value
Received intended cycles of therapy, n (%)155 (82.4)236 (76.0).08
CTC grades 3 and 4 toxicity, n (%)14 (7.5)29 (9.3).60
Toxicity-related hospitalization, n (%)11 (5.9)13 (4.2).28
Percent change in CA 19-9, mean (SD)-54.4 (56.9)7.0 (453.1).14
Radiographic response partial/stable, n (%)161 (85.6)245 (78.3).09

*Adjusted for age, race, sex, ECOG, NLR, PNI, and chemotherapy.

Table 2.
Open in new tab

Therapeutic outcomes* at initial restaging.

PERT
(n = 188)		No PERT
(n = 313)		P-value
Received intended cycles of therapy, n (%)155 (82.4)236 (76.0).08
CTC grades 3 and 4 toxicity, n (%)14 (7.5)29 (9.3).60
Toxicity-related hospitalization, n (%)11 (5.9)13 (4.2).28
Percent change in CA 19-9, mean (SD)-54.4 (56.9)7.0 (453.1).14
Radiographic response partial/stable, n (%)161 (85.6)245 (78.3).09
PERT
(n = 188)		No PERT
(n = 313)		P-value
Received intended cycles of therapy, n (%)155 (82.4)236 (76.0).08
CTC grades 3 and 4 toxicity, n (%)14 (7.5)29 (9.3).60
Toxicity-related hospitalization, n (%)11 (5.9)13 (4.2).28
Percent change in CA 19-9, mean (SD)-54.4 (56.9)7.0 (453.1).14
Radiographic response partial/stable, n (%)161 (85.6)245 (78.3).09

*Adjusted for age, race, sex, ECOG, NLR, PNI, and chemotherapy.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close